Navigation Links
Mylan Receives Approval for Nabumetone Tablets
Date:7/14/2010

PITTSBURGH, July 14 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nabumetone Tablets USP, 500 mg and 750 mg. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Nabumetone Tablets, a treatment for osteoarthritis and rheumatoid arthritis. The product will be distributed by Mylan Pharmaceuticals Inc.

Nabumetone Tablets had U.S. sales of approximately $68 million for the 12 months ending March 31, 2010, according to IMS Health.

Currently, Mylan has 134 ANDAs pending FDA approval representing $93.8 billion in annual brand sales, according to IMS Health. Thirty-nine of these pending ANDAs are potential first-to-file opportunities, representing $20.2 billion in annual brand sales, for the 12 months ending Dec. 31, 2009 according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Schedules Second Quarter 2010 Financial Results Conference Call and Live Webcast
2. Mylan Receives Approval for Generic Version of Arimidex® Tablets
3. Mylan Receives Approval for Generic Version of Zocor® Tablets
4. Mylan Receives Approval for Hydroxyzine Hydrochloride Tablets
5. Mylan Receives Approval for Generic Version of Neurontin® Tablets
6. Mylan Receives Approval for Generic Version of Valtrex®
7. Mylan Launches Temazepam Capsules USP, 7.5 mg
8. Mylan Announces Completion of Senior Notes Offering
9. Mylan Announces Upsizing and Pricing of Senior Notes
10. Mylan Announces Proposed Senior Notes Private Placement
11. Mylan Receives Approval for Generic Version of Zyban(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... May 6, 2016 Appoints ... and its Application to Drug Development Including Development of ... , the life sciences consulting firm, today announced that ... an Associate Partner in its Cambridge, MA ... Miller, PhD, in the firm,s Medical Imaging consulting practice ...
(Date:5/5/2016)... International plc (NASDAQ: ENDP ) (TSX: ENL) today ... president of Allergan, Inc. and current CEO of Chase Pharmaceuticals ... TPG Capital, to its Board of Directors. The appointments are ... recently embarked on a search for new Board members who ... and Todd are experienced leaders, and we are extremely pleased ...
(Date:5/5/2016)... DUBLIN , May 5, 2016 ... "Market Report for PET Imaging in the USA"  report ... ,This report provides information on the current Positron Emission ... USA market. Along with the ... the USA , the report also ...
Breaking Medicine Technology:
(Date:5/6/2016)... PA (PRWEB) , ... May 06, 2016 , ... ... does to reduce fat areas around the body, is the most popular ... survey results just released make perfect sense to cosmetic surgeon Dr. Richard Buckley, ...
(Date:5/6/2016)... ... May 06, 2016 , ... From May 4 to ... offering EarQ members the unique opportunity to learn more about Signia’s technology and the ... growth. , “It is our priority to see practices succeed in this highly competitive ...
(Date:5/6/2016)... ... 2016 , ... The International Yoga Teacher Training schoo l will ... close to the town famous for its sunsets, Oia. This all inclusive yoga training ... have an amazing experience in Greece, we just can’t stay away” says Co-Founder Carri ...
(Date:5/6/2016)... , ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... worldwide, what he has found in the Bible about helping to stop cancer. Yisrayl says ... it is his hope that the health and science industries will pay close attention and ...
(Date:5/6/2016)... ... May 06, 2016 , ... This Mother’s Day kicks ... everywhere. The 17th annual National Women’s Health Week takes place May 8-May ... Health are combining forces to empower women to make their health a top priority. ...
Breaking Medicine News(10 mins):